Global Suprapubic Catheter Market, by Indication (Benign Prostate Hyperplasia, Urinary Incontinence, and Others), by Material (Rubber, Plastic, and Polyvinyl Chloride), by End User (Hospitals, Ambulatory Surgical Centers, Urology Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 15,392.75 Million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing demand for suprapubic catheters, owing to rising prevalence of bladder cancer is expected to be a major factor driving the suprapubic catheter market over the forecast period. For instance, according to American Cancer Society, around 80,470 new cases of bladder cancer were expected in the U.S. in 2019. Among these, estimated cases of bladder cancer in men were 61,700 and 18,770 cases of bladder cancer in women.
Global Suprapubic Catheter Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a negative impact on the global suprapubic catheter market, owing to disruption in supply chain of raw materials and decrease in the research and development activities carried out for suprapubic catheters. For instance, in July 2020, according to the data published by the National Center for Biotechnology Information, the worldwide supply chain continues to be affected by challenges relating to the COVID-19 pandemic, including delays and disruption. In some areas, it brought to light previously unseen vulnerabilities, and of course, several organizations had suffered staff shortages and losses due to COVID-19 during manufacturing of suprapubic catheters. The government of different countries imposed lockdown which restricted the import and export across the world. The coronavirus (COVID-19) pandemic has impacted health systems worldwide. There is a continuing need for clinicians to adapt practice to facilitate timely provision of medical care, whilst minimising horizontal transmission. Guidance and recommendations are increasingly available, and this rapid review aimed to provide a timely evidence synthesis on the current recommendations surrounding urogynaecological care. Due to the high number of appointments of COVID-19 patients, the normal health system has lost its ordinal functioning. COVID-19 brought a heavy burden on all health systems especially in the first wave of outbreak. Therefore, face-to-face outpatient and nonurgent activities have been postponed in many hospitals.
Global Suprapubic Catheter Market: Key Developments
In March 2021, Teleflex, a surgical and medical instrument manufacturing company, launched its Rüsch suprapubic urine drainage systems form a line of instruments perfectly adapted to each other. They provide a well-tolerated alternative to transurethral drainage, enabling simple and safe handling and the greatest possible comfort during wear in short, medium and long-term care, at the same time minimizing the risk of infection.
Browse 34 Market Data Tables and 27 Figures spread through 160 Pages and in-depth TOC on “Global Suprapubic Catheter Market”- Forecast to 2030, Global Suprapubic Catheter Market, by Indication (Benign Prostate Hyperplasia, Urinary Incontinence, and Others), by Material (Rubber, Plastic, and Polyvinyl Chloride), by End User (Hospitals, Ambulatory Surgical Centers, Urology Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/suprapubic-catheter-market-2616
Moreover, increasing preference for suprapubic catheters over indwelling catheters, owing to complications associated with indwelling catheters including epididymitis, hematuria, bladder stones, and bladder cancer is expected to boost the suprapubic catheter market growth. For instance, in 2018, in a study at Veterans Affairs (VA) Medical Center, integrated health care system in the United States 42% of catheterized patients with indwelling catheter were uncomfortable, 48% complained about pain, and 61% of catheterized patients with indwelling catheters experienced restriction in body activities.
Key Takeaways of the Global Suprapubic Catheter Market:
- Global suprapubic catheter market is expected to exhibit a CAGR of 7.3% during the forecast period owing to continuous technological advancements in suprapubic catheterization. For instance, in April 2017, Mediplus Ltd. Received ‘Queen’s Award for Enterprise’ in the category of innovation for its S-Cath System.
- Among regions, North America is estimated to account for the largest market share in the global suprapubic catheter market over the forecast period, owing to the increasing prevalence of the kidney cancer and bladder cancer in the region. For instance, American Cancer Society, about 81,180 new cases of bladder cancer (about 61,700 in men and 19,480 in women) in 2021. About 17,100 deaths from bladder cancer (about 12,120 in men and 4,980 in women) in the year 2021.
- Increasing incidences of urology disorders such as urinary incontinence and bladder cancer in geriatric population as well as rising number of patients undergoing Kidney and bladder surgeries in hospitals are resulting in increasing demand for suprapubic catheters in the global market
- Major players operating in the global suprapubic catheter market include Amecath, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook Medical, Teleflex Incorporated, Fortune Medical Instrument Corp, Degania Silicone Ltd., Bard Medical, Urovision GmbH, UroTech Inc., and UroMed
